Helicobacter pylorn. The organism is slow growing and early cultures were discarded prematurely. Only during the Easter holiday was sufficient time left for colonies to develop.5 In retrospect, the intervention of a religious festival seems entirely appropriate. H pylori attracts great loyalty from its devotees. 'Pylorites' accept that the organism causes gastritis, duodenal ulcer, and non-ulcer dyspepsia. In contrast 'Schwartzians,' who attribute all disease to acid, remain sceptical; the undisputed efficacy of the H2 receptor antagonists being the cornerstone of their credo. Currently, there is the need for a middle ground to bridge the credibility gap. What facts are accepted and in which areas should we focus research? Epidemiology H pylon has been found in all human populations studied to date."'0 In western countries the carriage rate is low among children, but rises progressively through life. At least 50% of those over the age of 50 are positive for H pyloi.6 In contrast the limited data from the third world suggest that a greater percentage of the population may be colonised in childhood. 8' " The source of infection is unknown. One report suggests that the carriage rate among abattoir workers in close proximity to animals is greater than in their clerical counterparts." To date the only animal, other than humans, from which H pylori has been isolated is the rhesus monkey. 12 There are virtually no reports of isolations of helicobacter-like organisms from domesticated animals. '3 We think that it is more likely that the source of the organism will prove to be other humans. The relation between gastric metaplasia and acid secretion is interesting. Metaplasia is said to occur only in patients with a low fasting pH, to be extensive in those with the Zollinger-Ellison syndrome, and to correlate with maximal acid output.50 Animal experiments also indicate a link with acid secretion. Some of the data are old, however, and the subject deserves prospective re-evaluation.
Gastric metaplasia is essentially a microscopic diagnosis, and while the determination of its extent within an individual biopsy specimen is straightforward, it is difficult to extrapolate this to the duodenal cap as a whole. The problem of sampling error will always remain.
More importantly, can the hypothesis explain some of the known differences between the epidemiology of duodenal ulcer and the carriage of H pylori? Duodenal ulcer is more common in the north of the United Kingdom, affects younger people, and shows a male preponderance. There is no evidence to date that H pylori is more common in the north or among men, and its incidence rises progressively with age. Gastric metaplasia is, however, more common in men. 52 Levi It has been known for many years that bismuth salts can heal ulcers. The suggestion that duodenal ulcer relapse occurs less frequently after treatment with tripotassium dicitratobismuthate (DeNol) was given greater credibility in 1981 with the publication of a study comparing it and H2 blockers.6' The discovery that H pylon is sensitive to bismuth in vitro prompted new questions regarding the mechanism of action of tripotassium dicitratobismuthate and the role of H pylon in ulcer relapse. A number of studies now suggest that in patients with duodenal ulcer, in whom the organism is successfully eradicated and who remain free of H pylon for longer than one month, the ulcer relapse rate is 1O-20%.62 This is significantly lower than in control groups treated with H2 blockers. Recurrence of the organism seems to predict relapse. The problem remains, however, that H pylon may be acting as a marker for other factors operating within the gastric environment. For example, it could be argued that healing the ulcer itself may alter conditions in such a way as to make the upper gastrointestinal tract less hospitable to the bacterium. This seems unlikely because the carriage rate for H pylon remains unchanged in patients whose ulcers are healed by H2 blockers.63 More importantly, the low ulcer recurrence rate may be directly related to tripotassium dicitratobismuthate itself, which is known to have actions unrelated to its bactericidal activity. Tripotassium dicitratobismuthate has been shown to form complexes with mucus,6519 making it more effective as a diffusion barrier to hydrogen ion. It reduces pepsin output and activity70 and promotes prostaglandin synthesis."1 Some bismuth is absorbed during treatment72 and this may act as a depot within the gastric mucosa. What is less clear, however, is whether plasma or urine concentrations truly reflect bismuth values within the gastric mucosa, and whether these concentrations would be sufficient to eradicate or suppress the growth of the organism. This seems unlikely in view of the relative inefficiency of tripotassium dicitratobismuthate alone in the eradication of H pylori, with rates as low as 5-33% one month after treatment.4373 It cannot be taken as proved, therefore, that H pylon is responsible for the lower duodenal ulcer relapse rate for duodenal ulcer after treatment with tripotassium dicitratobismuthate, but it is certainly possible that it has an important role in this respect.
GASTRIC ULCER
The association with gastric ulcer is less strong with only 65% of these patients being positive for H pylori. 74 
